XVIVO Perfusion AB: Patient Inclusion Completed in European Clinical Trial with XVIVO's Heart Preservation Technology
GOTHENBURG, SE / ACCESSWIRE / May 23, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) XVIVO's innovative heart technology is currently under investigation in a randomized controlled clinical trial
Vastra Gotalands Lan New Zealand Gewinn Nur Andreas Wallinder Christoffer Rosenblad Kristoffer Nordstr
Source: finanznachrichten.de